Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T

Background MRI is one of the most important techniques to assess the treatment response of gliomas. However, differentiating tumor recurrence (TuR) from treatment effects (TrE) remains challenging. Purpose To compare the diagnostic performance of MR diffusion‐weighted imaging (DWI), arterial spin la...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of magnetic resonance imaging 2020-04, Vol.51 (4), p.1154-1161
Hauptverfasser: Liu, Jie, Li, Cong, Chen, Yinsheng, Lv, Xiaofei, Lv, Yanchun, Zhou, Jian, Xi, Shaoyan, Dou, Weiqiang, Qian, Long, Zheng, Hairong, Wu, Yin, Chen, Zhongping
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1161
container_issue 4
container_start_page 1154
container_title Journal of magnetic resonance imaging
container_volume 51
creator Liu, Jie
Li, Cong
Chen, Yinsheng
Lv, Xiaofei
Lv, Yanchun
Zhou, Jian
Xi, Shaoyan
Dou, Weiqiang
Qian, Long
Zheng, Hairong
Wu, Yin
Chen, Zhongping
description Background MRI is one of the most important techniques to assess the treatment response of gliomas. However, differentiating tumor recurrence (TuR) from treatment effects (TrE) remains challenging. Purpose To compare the diagnostic performance of MR diffusion‐weighted imaging (DWI), arterial spin labeling (ASL), proton MR spectroscopy (MRS), and amide proton transfer (APT) imaging in differentiating between TuR and TrE in posttreatment glioma patients. Study Type Prospective. Population Thirty patients with suspected tumor progression. Field Strength/Sequence DWI, ASL, proton MRS, and APT imaging were performed at 3T MR. Assessment MR indices, including ADC, relative cerebral blood flow (rCBF), ratios of Cho/Cr, Cho/NAA, and NAA/Cr and APT‐weighted (APTw) effect were obtained from DWI, ASL, proton MRS, and APT imaging, respectively. Indices were measured in the contralateral normal‐appearing white matter and lesions defined on the Gd‐enhanced T1w image. TuR or TrE was either determined histologically or clinically from longitudinal MRI follow‐up for at least 6 months. Statistical Tests The diagnostic performance of the indices was evaluated using Student's t‐test, receiver operating characteristic (ROC) curve, and multivariate logistic regression analyses. Results Among the 30 patients, 16 were diagnosed as having TuR and the rest having TrE. The recurrent tumors showed a significantly higher APTw effect (1.56 ± 1.14%) and rCBF (1.44 ± 0.61) compared with lesions representing treatment effects (–0.44 ± 1.34% and 0.72 ± 0.25, respectively, with P 
doi_str_mv 10.1002/jmri.26900
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2335171225</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2375713111</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4230-f474a1bd01ca5c76abf43d25b20107e75b10dd04be1c1e14b2280871068b8b593</originalsourceid><addsrcrecordid>eNp90cFqFTEUBuAgiq3VjQ8gATciTD0nmdzMXUpttaUiSF0PycyZmsskGZOM0rc311tduOgqCefjJ5yfsZcIpwgg3u18cqdiswV4xI5RCdEI1W0e1zso2WAH-og9y3kHANttq56yI4mtrK_umIUPztyGmIsb-EJpismbMBCPE_frXNxikvFUUh1__nrJXeDlO3H6aebVFBfDHpZEpngKhSfKSwyZ9u52dtEbvlRWR5mbwuXNc_ZkMnOmF_fnCft2cX5z9qm5_vLx8uz9dTO0QkIztbo1aEfAwahBb4ydWjkKZQUgaNLKIowjtJZwQMLWCtFBpxE2ne2s2soT9uaQu6T4Y6Vceu_yQPNsAsU190JKhRqFUJW-_o_u4ppC_V1VWmmUiFjV24MaUsw50dQvyXmT7nqEft9Cv2-h_9NCxa_uI1frafxH_669AjyAX26muwei-qu69UPobwqkkcY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2375713111</pqid></control><display><type>article</type><title>Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T</title><source>MEDLINE</source><source>Wiley Journals</source><creator>Liu, Jie ; Li, Cong ; Chen, Yinsheng ; Lv, Xiaofei ; Lv, Yanchun ; Zhou, Jian ; Xi, Shaoyan ; Dou, Weiqiang ; Qian, Long ; Zheng, Hairong ; Wu, Yin ; Chen, Zhongping</creator><creatorcontrib>Liu, Jie ; Li, Cong ; Chen, Yinsheng ; Lv, Xiaofei ; Lv, Yanchun ; Zhou, Jian ; Xi, Shaoyan ; Dou, Weiqiang ; Qian, Long ; Zheng, Hairong ; Wu, Yin ; Chen, Zhongping</creatorcontrib><description>Background MRI is one of the most important techniques to assess the treatment response of gliomas. However, differentiating tumor recurrence (TuR) from treatment effects (TrE) remains challenging. Purpose To compare the diagnostic performance of MR diffusion‐weighted imaging (DWI), arterial spin labeling (ASL), proton MR spectroscopy (MRS), and amide proton transfer (APT) imaging in differentiating between TuR and TrE in posttreatment glioma patients. Study Type Prospective. Population Thirty patients with suspected tumor progression. Field Strength/Sequence DWI, ASL, proton MRS, and APT imaging were performed at 3T MR. Assessment MR indices, including ADC, relative cerebral blood flow (rCBF), ratios of Cho/Cr, Cho/NAA, and NAA/Cr and APT‐weighted (APTw) effect were obtained from DWI, ASL, proton MRS, and APT imaging, respectively. Indices were measured in the contralateral normal‐appearing white matter and lesions defined on the Gd‐enhanced T1w image. TuR or TrE was either determined histologically or clinically from longitudinal MRI follow‐up for at least 6 months. Statistical Tests The diagnostic performance of the indices was evaluated using Student's t‐test, receiver operating characteristic (ROC) curve, and multivariate logistic regression analyses. Results Among the 30 patients, 16 were diagnosed as having TuR and the rest having TrE. The recurrent tumors showed a significantly higher APTw effect (1.56 ± 1.14%) and rCBF (1.44 ± 0.61) compared with lesions representing treatment effects (–0.44 ± 1.34% and 0.72 ± 0.25, respectively, with P &lt; 0.001). The areas under the curve (AUCs) were 0.87 and 0.90 for APTw and rCBF, respectively, in differentiating between TuR and TrE. Combining APTw and rCBF achieved a higher AUC of 0.93. MRS index ratios of Cho/Cr (P = 0.25), Cho/NAA (P = 0.16), and NAA/Cr (P = 0.86) and ADC (P = 0.37) showed no significant differences between TuR and TrE lesions, with AUCs lower than 0.70. Data Conclusion Compared with DWI and MRS, ASL and APT imaging techniques showed better diagnostic capability in distinguishing TuR from TrE. Level of Evidence: 1 Technical Efficacy: Stage 4 J. Magn. Reson. Imaging 2020;51:1154–1161.</description><identifier>ISSN: 1053-1807</identifier><identifier>EISSN: 1522-2586</identifier><identifier>DOI: 10.1002/jmri.26900</identifier><identifier>PMID: 31430008</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley &amp; Sons, Inc</publisher><subject>amide proton transfer imaging ; Blood flow ; Brain Neoplasms - diagnostic imaging ; Brain Neoplasms - therapy ; Brain tumors ; Cerebral blood flow ; diagnostic performance ; Diagnostic systems ; Diffusion Magnetic Resonance Imaging ; Field strength ; Gadolinium ; Glioma ; Glioma - diagnostic imaging ; Glioma - therapy ; Humans ; Image enhancement ; Imaging techniques ; Lesions ; Magnetic Resonance Imaging ; Magnetic resonance spectroscopy ; Medical imaging ; Multiparametric Magnetic Resonance Imaging ; Neoplasm Recurrence, Local ; Population studies ; Prospective Studies ; Protons ; Regression analysis ; Spin labeling ; Statistical analysis ; Statistical tests ; Substantia alba ; treatment effects ; tumor recurrence ; Tumors</subject><ispartof>Journal of magnetic resonance imaging, 2020-04, Vol.51 (4), p.1154-1161</ispartof><rights>2019 International Society for Magnetic Resonance in Medicine</rights><rights>2019 International Society for Magnetic Resonance in Medicine.</rights><rights>2020 International Society for Magnetic Resonance in Medicine</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4230-f474a1bd01ca5c76abf43d25b20107e75b10dd04be1c1e14b2280871068b8b593</citedby><cites>FETCH-LOGICAL-c4230-f474a1bd01ca5c76abf43d25b20107e75b10dd04be1c1e14b2280871068b8b593</cites><orcidid>0000-0002-4323-5083 ; 0000-0002-1712-630X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjmri.26900$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjmri.26900$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31430008$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liu, Jie</creatorcontrib><creatorcontrib>Li, Cong</creatorcontrib><creatorcontrib>Chen, Yinsheng</creatorcontrib><creatorcontrib>Lv, Xiaofei</creatorcontrib><creatorcontrib>Lv, Yanchun</creatorcontrib><creatorcontrib>Zhou, Jian</creatorcontrib><creatorcontrib>Xi, Shaoyan</creatorcontrib><creatorcontrib>Dou, Weiqiang</creatorcontrib><creatorcontrib>Qian, Long</creatorcontrib><creatorcontrib>Zheng, Hairong</creatorcontrib><creatorcontrib>Wu, Yin</creatorcontrib><creatorcontrib>Chen, Zhongping</creatorcontrib><title>Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T</title><title>Journal of magnetic resonance imaging</title><addtitle>J Magn Reson Imaging</addtitle><description>Background MRI is one of the most important techniques to assess the treatment response of gliomas. However, differentiating tumor recurrence (TuR) from treatment effects (TrE) remains challenging. Purpose To compare the diagnostic performance of MR diffusion‐weighted imaging (DWI), arterial spin labeling (ASL), proton MR spectroscopy (MRS), and amide proton transfer (APT) imaging in differentiating between TuR and TrE in posttreatment glioma patients. Study Type Prospective. Population Thirty patients with suspected tumor progression. Field Strength/Sequence DWI, ASL, proton MRS, and APT imaging were performed at 3T MR. Assessment MR indices, including ADC, relative cerebral blood flow (rCBF), ratios of Cho/Cr, Cho/NAA, and NAA/Cr and APT‐weighted (APTw) effect were obtained from DWI, ASL, proton MRS, and APT imaging, respectively. Indices were measured in the contralateral normal‐appearing white matter and lesions defined on the Gd‐enhanced T1w image. TuR or TrE was either determined histologically or clinically from longitudinal MRI follow‐up for at least 6 months. Statistical Tests The diagnostic performance of the indices was evaluated using Student's t‐test, receiver operating characteristic (ROC) curve, and multivariate logistic regression analyses. Results Among the 30 patients, 16 were diagnosed as having TuR and the rest having TrE. The recurrent tumors showed a significantly higher APTw effect (1.56 ± 1.14%) and rCBF (1.44 ± 0.61) compared with lesions representing treatment effects (–0.44 ± 1.34% and 0.72 ± 0.25, respectively, with P &lt; 0.001). The areas under the curve (AUCs) were 0.87 and 0.90 for APTw and rCBF, respectively, in differentiating between TuR and TrE. Combining APTw and rCBF achieved a higher AUC of 0.93. MRS index ratios of Cho/Cr (P = 0.25), Cho/NAA (P = 0.16), and NAA/Cr (P = 0.86) and ADC (P = 0.37) showed no significant differences between TuR and TrE lesions, with AUCs lower than 0.70. Data Conclusion Compared with DWI and MRS, ASL and APT imaging techniques showed better diagnostic capability in distinguishing TuR from TrE. Level of Evidence: 1 Technical Efficacy: Stage 4 J. Magn. Reson. Imaging 2020;51:1154–1161.</description><subject>amide proton transfer imaging</subject><subject>Blood flow</subject><subject>Brain Neoplasms - diagnostic imaging</subject><subject>Brain Neoplasms - therapy</subject><subject>Brain tumors</subject><subject>Cerebral blood flow</subject><subject>diagnostic performance</subject><subject>Diagnostic systems</subject><subject>Diffusion Magnetic Resonance Imaging</subject><subject>Field strength</subject><subject>Gadolinium</subject><subject>Glioma</subject><subject>Glioma - diagnostic imaging</subject><subject>Glioma - therapy</subject><subject>Humans</subject><subject>Image enhancement</subject><subject>Imaging techniques</subject><subject>Lesions</subject><subject>Magnetic Resonance Imaging</subject><subject>Magnetic resonance spectroscopy</subject><subject>Medical imaging</subject><subject>Multiparametric Magnetic Resonance Imaging</subject><subject>Neoplasm Recurrence, Local</subject><subject>Population studies</subject><subject>Prospective Studies</subject><subject>Protons</subject><subject>Regression analysis</subject><subject>Spin labeling</subject><subject>Statistical analysis</subject><subject>Statistical tests</subject><subject>Substantia alba</subject><subject>treatment effects</subject><subject>tumor recurrence</subject><subject>Tumors</subject><issn>1053-1807</issn><issn>1522-2586</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp90cFqFTEUBuAgiq3VjQ8gATciTD0nmdzMXUpttaUiSF0PycyZmsskGZOM0rc311tduOgqCefjJ5yfsZcIpwgg3u18cqdiswV4xI5RCdEI1W0e1zso2WAH-og9y3kHANttq56yI4mtrK_umIUPztyGmIsb-EJpismbMBCPE_frXNxikvFUUh1__nrJXeDlO3H6aebVFBfDHpZEpngKhSfKSwyZ9u52dtEbvlRWR5mbwuXNc_ZkMnOmF_fnCft2cX5z9qm5_vLx8uz9dTO0QkIztbo1aEfAwahBb4ydWjkKZQUgaNLKIowjtJZwQMLWCtFBpxE2ne2s2soT9uaQu6T4Y6Vceu_yQPNsAsU190JKhRqFUJW-_o_u4ppC_V1VWmmUiFjV24MaUsw50dQvyXmT7nqEft9Cv2-h_9NCxa_uI1frafxH_669AjyAX26muwei-qu69UPobwqkkcY</recordid><startdate>202004</startdate><enddate>202004</enddate><creator>Liu, Jie</creator><creator>Li, Cong</creator><creator>Chen, Yinsheng</creator><creator>Lv, Xiaofei</creator><creator>Lv, Yanchun</creator><creator>Zhou, Jian</creator><creator>Xi, Shaoyan</creator><creator>Dou, Weiqiang</creator><creator>Qian, Long</creator><creator>Zheng, Hairong</creator><creator>Wu, Yin</creator><creator>Chen, Zhongping</creator><general>John Wiley &amp; Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>7TK</scope><scope>8FD</scope><scope>FR3</scope><scope>K9.</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4323-5083</orcidid><orcidid>https://orcid.org/0000-0002-1712-630X</orcidid></search><sort><creationdate>202004</creationdate><title>Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T</title><author>Liu, Jie ; Li, Cong ; Chen, Yinsheng ; Lv, Xiaofei ; Lv, Yanchun ; Zhou, Jian ; Xi, Shaoyan ; Dou, Weiqiang ; Qian, Long ; Zheng, Hairong ; Wu, Yin ; Chen, Zhongping</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4230-f474a1bd01ca5c76abf43d25b20107e75b10dd04be1c1e14b2280871068b8b593</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>amide proton transfer imaging</topic><topic>Blood flow</topic><topic>Brain Neoplasms - diagnostic imaging</topic><topic>Brain Neoplasms - therapy</topic><topic>Brain tumors</topic><topic>Cerebral blood flow</topic><topic>diagnostic performance</topic><topic>Diagnostic systems</topic><topic>Diffusion Magnetic Resonance Imaging</topic><topic>Field strength</topic><topic>Gadolinium</topic><topic>Glioma</topic><topic>Glioma - diagnostic imaging</topic><topic>Glioma - therapy</topic><topic>Humans</topic><topic>Image enhancement</topic><topic>Imaging techniques</topic><topic>Lesions</topic><topic>Magnetic Resonance Imaging</topic><topic>Magnetic resonance spectroscopy</topic><topic>Medical imaging</topic><topic>Multiparametric Magnetic Resonance Imaging</topic><topic>Neoplasm Recurrence, Local</topic><topic>Population studies</topic><topic>Prospective Studies</topic><topic>Protons</topic><topic>Regression analysis</topic><topic>Spin labeling</topic><topic>Statistical analysis</topic><topic>Statistical tests</topic><topic>Substantia alba</topic><topic>treatment effects</topic><topic>tumor recurrence</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liu, Jie</creatorcontrib><creatorcontrib>Li, Cong</creatorcontrib><creatorcontrib>Chen, Yinsheng</creatorcontrib><creatorcontrib>Lv, Xiaofei</creatorcontrib><creatorcontrib>Lv, Yanchun</creatorcontrib><creatorcontrib>Zhou, Jian</creatorcontrib><creatorcontrib>Xi, Shaoyan</creatorcontrib><creatorcontrib>Dou, Weiqiang</creatorcontrib><creatorcontrib>Qian, Long</creatorcontrib><creatorcontrib>Zheng, Hairong</creatorcontrib><creatorcontrib>Wu, Yin</creatorcontrib><creatorcontrib>Chen, Zhongping</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of magnetic resonance imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liu, Jie</au><au>Li, Cong</au><au>Chen, Yinsheng</au><au>Lv, Xiaofei</au><au>Lv, Yanchun</au><au>Zhou, Jian</au><au>Xi, Shaoyan</au><au>Dou, Weiqiang</au><au>Qian, Long</au><au>Zheng, Hairong</au><au>Wu, Yin</au><au>Chen, Zhongping</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T</atitle><jtitle>Journal of magnetic resonance imaging</jtitle><addtitle>J Magn Reson Imaging</addtitle><date>2020-04</date><risdate>2020</risdate><volume>51</volume><issue>4</issue><spage>1154</spage><epage>1161</epage><pages>1154-1161</pages><issn>1053-1807</issn><eissn>1522-2586</eissn><abstract>Background MRI is one of the most important techniques to assess the treatment response of gliomas. However, differentiating tumor recurrence (TuR) from treatment effects (TrE) remains challenging. Purpose To compare the diagnostic performance of MR diffusion‐weighted imaging (DWI), arterial spin labeling (ASL), proton MR spectroscopy (MRS), and amide proton transfer (APT) imaging in differentiating between TuR and TrE in posttreatment glioma patients. Study Type Prospective. Population Thirty patients with suspected tumor progression. Field Strength/Sequence DWI, ASL, proton MRS, and APT imaging were performed at 3T MR. Assessment MR indices, including ADC, relative cerebral blood flow (rCBF), ratios of Cho/Cr, Cho/NAA, and NAA/Cr and APT‐weighted (APTw) effect were obtained from DWI, ASL, proton MRS, and APT imaging, respectively. Indices were measured in the contralateral normal‐appearing white matter and lesions defined on the Gd‐enhanced T1w image. TuR or TrE was either determined histologically or clinically from longitudinal MRI follow‐up for at least 6 months. Statistical Tests The diagnostic performance of the indices was evaluated using Student's t‐test, receiver operating characteristic (ROC) curve, and multivariate logistic regression analyses. Results Among the 30 patients, 16 were diagnosed as having TuR and the rest having TrE. The recurrent tumors showed a significantly higher APTw effect (1.56 ± 1.14%) and rCBF (1.44 ± 0.61) compared with lesions representing treatment effects (–0.44 ± 1.34% and 0.72 ± 0.25, respectively, with P &lt; 0.001). The areas under the curve (AUCs) were 0.87 and 0.90 for APTw and rCBF, respectively, in differentiating between TuR and TrE. Combining APTw and rCBF achieved a higher AUC of 0.93. MRS index ratios of Cho/Cr (P = 0.25), Cho/NAA (P = 0.16), and NAA/Cr (P = 0.86) and ADC (P = 0.37) showed no significant differences between TuR and TrE lesions, with AUCs lower than 0.70. Data Conclusion Compared with DWI and MRS, ASL and APT imaging techniques showed better diagnostic capability in distinguishing TuR from TrE. Level of Evidence: 1 Technical Efficacy: Stage 4 J. Magn. Reson. Imaging 2020;51:1154–1161.</abstract><cop>Hoboken, USA</cop><pub>John Wiley &amp; Sons, Inc</pub><pmid>31430008</pmid><doi>10.1002/jmri.26900</doi><tpages>8</tpages><orcidid>https://orcid.org/0000-0002-4323-5083</orcidid><orcidid>https://orcid.org/0000-0002-1712-630X</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1053-1807
ispartof Journal of magnetic resonance imaging, 2020-04, Vol.51 (4), p.1154-1161
issn 1053-1807
1522-2586
language eng
recordid cdi_proquest_miscellaneous_2335171225
source MEDLINE; Wiley Journals
subjects amide proton transfer imaging
Blood flow
Brain Neoplasms - diagnostic imaging
Brain Neoplasms - therapy
Brain tumors
Cerebral blood flow
diagnostic performance
Diagnostic systems
Diffusion Magnetic Resonance Imaging
Field strength
Gadolinium
Glioma
Glioma - diagnostic imaging
Glioma - therapy
Humans
Image enhancement
Imaging techniques
Lesions
Magnetic Resonance Imaging
Magnetic resonance spectroscopy
Medical imaging
Multiparametric Magnetic Resonance Imaging
Neoplasm Recurrence, Local
Population studies
Prospective Studies
Protons
Regression analysis
Spin labeling
Statistical analysis
Statistical tests
Substantia alba
treatment effects
tumor recurrence
Tumors
title Diagnostic performance of multiparametric MRI in the evaluation of treatment response in glioma patients at 3T
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T23%3A08%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Diagnostic%20performance%20of%20multiparametric%20MRI%20in%20the%20evaluation%20of%20treatment%20response%20in%20glioma%20patients%20at%203T&rft.jtitle=Journal%20of%20magnetic%20resonance%20imaging&rft.au=Liu,%20Jie&rft.date=2020-04&rft.volume=51&rft.issue=4&rft.spage=1154&rft.epage=1161&rft.pages=1154-1161&rft.issn=1053-1807&rft.eissn=1522-2586&rft_id=info:doi/10.1002/jmri.26900&rft_dat=%3Cproquest_cross%3E2375713111%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2375713111&rft_id=info:pmid/31430008&rfr_iscdi=true